-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Context Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2020 to Q3 2024.
- Context Therapeutics Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 80.5M shares, a 404% increase year-over-year.
- Context Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 16M shares, unchanged from 2022.
- Context Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 16M shares, a 463% increase from 2021.
- Context Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 2.83M shares, a 37.9% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)